These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18083387)

  • 21. HCV infection in blood donors.
    Finch RG
    Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):541. PubMed ID: 7858807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 23. Hidden risk of hepatitis C.
    Greenberger P
    J Womens Health; 1998 Sep; 7(7):797-8. PubMed ID: 9785303
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current status of transfusion-transmitted infection].
    Shimizu M
    Rinsho Ketsueki; 1993 Apr; 34(4):411-7. PubMed ID: 8510326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 26. [Investigation and preventive strategy of post-transfusion hepatitis C virus infection].
    Feng L; Yang UF
    Zhonghua Hu Li Za Zhi; 1996 Jun; 31(6):316-8. PubMed ID: 8945146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of gamma-globulin in prevention of fibrinogen-transmitted hepatitis.
    Ekblom L; Olsson P; Aberg T
    Acta Chir Scand; 1967; 133(5):351-4. PubMed ID: 4167870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of infection with hepatitis C virus in medical personnel as an aspect of risk management].
    Arakawa Y; Tanaka N; Kaneko M; Arakawa Y; Moriyama M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):297-312. PubMed ID: 15359810
    [No Abstract]   [Full Text] [Related]  

  • 30. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
    Takahashi M; Muraoka M; Tadokoro K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
    [No Abstract]   [Full Text] [Related]  

  • 31. [Unfavorable effects of transfusion at the Japanese Red Cross Central Blood Center].
    Juji T
    Rinsho Ketsueki; 1997 Apr; 38(4):245-8. PubMed ID: 9146043
    [No Abstract]   [Full Text] [Related]  

  • 32. Preventing transmission of hepatitis C.
    MacDonald M; Wodak A
    Aust Fam Physician; 2003 Oct; 32(10):799-803. PubMed ID: 14596074
    [No Abstract]   [Full Text] [Related]  

  • 33. [The hepatitis C problem in transfusions in military medicine].
    Danil'chenko VV; Zhiburt EB; Bel'gesov NV; Serebrianaia NB; Sidorkevich SV
    Voen Med Zh; 1994 Jun; (6):44-5, 80. PubMed ID: 7941454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis C and ALT in blood donors].
    García Bueno MJ
    Sangre (Barc); 1991 Jun; 36(3):252-3. PubMed ID: 1948551
    [No Abstract]   [Full Text] [Related]  

  • 35. [The prospect of non-A, non-B hepatitis research].
    Shikata T
    Nihon Rinsho; 1988 Dec; 46(12):2567-74. PubMed ID: 3149328
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of hepatitis C. How to update the pioneer work done by Eugène Jamot?].
    Coton T
    Presse Med; 2003 Sep; 32(29):1349-50. PubMed ID: 14534495
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-transfusion hepatitis: a problem in Northern Ireland?
    Bharucha C; Crowley D
    Ulster Med J; 1986 Apr; 55(1):23-7. PubMed ID: 3090757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No need for bad blood over bad blood.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 May; 15(5):487. PubMed ID: 25932570
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 40. [Post-transfusion hepatitis in operated uterine cancer patients].
    Hayase R; Tao Y; Tamada T; Kokeguchi S; Nakanishi Y; Hayashi Y; Kohno I; Kudoh T; Sekiba K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1305-8. PubMed ID: 2121866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.